Cargando…

Novel psychoactive substances: What educators need to know

Novel psychoactive substances (NPS) are synthetic, psychoactive drugs that are generally not under international regulatory control. NPS are frequently sold as alternatives to classic “street drugs” such as ecstasy or LSD. However, little is known about their pharmacology and toxicity and they there...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patterson, ZR, Young, MM, Vaccarino, FJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704356/ https://www.ncbi.nlm.nih.gov/pubmed/27756105 http://dx.doi.org/10.1002/cpt.538

Ejemplares similares

Five Medical Education Podcasts You Need to Know
por: Lomayesva, Natalie L., et al.
Publicado: (2020)

Adult Guardianship in Korea: What Do Psychiatrists Need to Know?
por: Lim, Hyun Kook
Publicado: (2018)

Health Literacy and People with Intellectual Disabilities: What We Know, What We Do Not Know, and What We Need: A Theoretical Discourse
por: Geukes, Cornelia, et al.
Publicado: (2019)

Novel Psychoactive Substances and Behavioral Addictions
por: Martinotti, Giovanni, et al.
Publicado: (2014)

Integration of Women Veterans into VA Quality Improvement Research Efforts: What Researchers Need to Know
por: Yano, Elizabeth M., et al.
Publicado: (2010)

Assessing the Risk Factors Associated with Malaria in the Highlands of Ethiopia: What Do We Need to Know?
por: Vajda, Élodie Anne, et al.
Publicado: (2017)

TAVR in 2017―What we know? What to expect?
por: Kourkoveli, Panagiota, et al.
Publicado: (2018)

Priapism associated with novel psychoactive substance abuse
por: Jones, Patrick, et al.
Publicado: (2015)

An Expanding World of Novel Psychoactive Substances: Opioids
por: Zawilska, Jolanta B.
Publicado: (2017)

Genotoxicity Evaluation of The Novel Psychoactive Substance MTTA
por: Lenzi, Monia, et al.
Publicado: (2023)

What to know before forecasting the flu
por: Chakraborty, Prithwish, et al.
Publicado: (2018)

Novel Psychoactive Substances: The Razor’s Edge between Therapeutical Potential and Psychoactive Recreational Misuse
por: Correia, Beatriz, et al.
Publicado: (2022)

Managing the financial risks of climate change and pandemics: What we know (and don't know)
por: Ranger, Nicola, et al.
Publicado: (2021)

Young brains on cannabis: It's time to clear the smoke
por: Porath‐Waller, AJ, et al.
Publicado: (2015)

Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016
por: Deen, Adrian A, et al.
Publicado: (2021)

Sex and Gender Differences in the Effects of Novel Psychoactive Substances
por: Fattore, Liana, et al.
Publicado: (2020)

In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters
por: Botha, Michelle J., et al.
Publicado: (2022)

We know what we want, it’s just not there
por: Freundlich, Robert E., et al.
Publicado: (2021)

ANALYTICALLY CONFIRMED PRESENCE OF PSYCHOACTIVE SUBSTANCES, ESPECIALLY NEW PSYCHOACTIVE SUBSTANCES IN A GROUP OF PATIENTS HOSPITALIZED WITH MENTAL AND BEHAVIOURAL DISORDERS DUE TO THE USE OF PSYCHOACTIVE SUBSTANCES DIAGNOSIS
por: Engelgardt, Piotr, et al.
Publicado: (2022)

Authoring a periodic adverse drug experience report…here's what you need to know!
por: Kulkarni, Tejashree N., et al.
Publicado: (2019)

Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders
por: Dal Farra, Deborah, et al.
Publicado: (2022)

What Do We Know About Remdesivir Drug Interactions?
por: Yang, Katherine
Publicado: (2020)

Editorial: Pharmacology of new psychoactive substances
por: Lutfy, K., et al.
Publicado: (2023)

Novel Psychoactive Substances in Young Adults with and without Psychiatric Comorbidities
por: Martinotti, Giovanni, et al.
Publicado: (2014)

The Evolving Definition of Education Scholarship: What the Clinician Educator Needs to Know
por: Ander, Douglas S., et al.
Publicado: (2017)

Preventing breast cancer now by acting on what we already know
por: Colditz, Graham A, et al.
Publicado: (2015)

Invited Perspective: Oil and Gas Development and Adverse Birth Outcomes: What More Do We Need to Know?
por: Deziel, Nicole C.
Publicado: (2021)

Pathogen-Reservoir Interactions: What We Do Not Know Likely Will Hurt Us
por: Calisher, Charles H.
Publicado: (2021)

The pathology behind glaucoma: what we already know using omics technologies
por: May, Caroline, et al.
Publicado: (2023)

Use of novel psychoactive substances by inpatients on general adult psychiatric wards
por: Stanley, Jack L, et al.
Publicado: (2016)

Novel Psychoactive Substances (NPS): a Study on Persian Language Websites
por: BIGDELI, Imanollah, et al.
Publicado: (2013)

Accidental Ingestion of a Novel Psychoactive Substance: A Case Report
por: Kant, Abhay, et al.
Publicado: (2020)

“Hot” and “Cold” Cognition in Users of Club Drugs/Novel Psychoactive Substances
por: Savulich, George, et al.
Publicado: (2021)

Psychoactive substances and the political ecology of mental distress
por: Aggarwal, Sunil K, et al.
Publicado: (2012)

PSYCHOACTIVE SUBSTANCE USE AMONG MEDICAL STUDENTS
por: Ali, R.V. Zulfikar, et al.
Publicado: (1994)

Banning Psychoactive Substances: A Slippery Slope
Publicado: (2015)

Experimentation with psychoactive substances by public school students
por: de Andrade, Maria Eliane, et al.
Publicado: (2017)

New Psychoactive Substances: A Matter of Time
por: Pantano, Flaminia, et al.
Publicado: (2019)

New psychoactive substances: a review and updates
por: Shafi, Abu, et al.
Publicado: (2020)

Psychoactive Substances Taken with Mephedrone and HCV Infection
por: Ordak, Michal, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sjvoqnsnbhnuko46hv8t6babsp